Claude Discovers Novel CRISPR-like Enzyme System in Phages

Anthropic announced that Claude identified ART (Array-associated Reverse Transcriptase), a new enzyme system in phages with CRISPR-like repetitive arrays. Using 950 agents over 21 hours and 210 million tokens, the AI independently discovered the system from over 200,000 reverse transcriptases. Its function remains unknown but it may be programmable.
Key insights
Details of the ART System Discovery
ART consists of a reverse transcriptase, an unknown partner gene, and a long array of equally spaced repetitive DNA sequences. The array is transcribed into a set of short RNAs, similar to CRISPR's programmable guide system. Existing systems with these structural features are known for DNA editing (like CRISPR), but ART's specific function is not yet determined. The discovery was made by Claude scanning raw phage DNA sequences.
AI-Driven Discovery Process
The entire process was nearly autonomous. Researchers gave an initial prompt to search for interesting reverse transcriptases in massive DNA databases. Approximately 950 Claude agents ran for 21 hours, consuming 210 million tokens. They screened over 200,000 reverse transcriptases, narrowed to 3,500 candidates, and finally selected the 20 most promising ones, producing human-readable reports. One agent identified the repetitive array while reading raw sequences, counted repeats, measured spacing, compared with known systems, and confirmed it was novel before submitting to human review.
Significance and Expert Endorsement
This is the first major biological discovery driven almost entirely by an AI agent. Tasks like genomic mining that typically take experts weeks to months were completed in under a day. CRISPR pioneer Feng Zhang from MIT reviewed the preprint and commented that this is a great example of AI agents contributing to biology and that such arrays deserve further study. Anthropic formed a new life sciences research team that conducted the work.
Anthropic's Life Sciences Lab and Collaboration Plans
Anthropic built a wet lab in the Bay Area for BSL-1 and BSL-2 research only, not involving human pathogens. All experiments were performed by human scientists. The tools used are the publicly available Claude Science and Claude Code, meaning other labs can replicate the AI-assisted hypothesis generation and validation pipeline. Anthropic is now inviting external scientists to propose collaborative research topics.